Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Inherited variation in GATA3 gene associated with relapse in children with leukemia

Inherited variation in GATA3 gene associated with relapse in children with leukemia

Eliminating tumors with engineered ‘off-the-shelf’ therapeutic T cells

Eliminating tumors with engineered ‘off-the-shelf’ therapeutic T cells

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

A genetic link discovered to predict treatment response for patients with rare, aggressive cancer

Combination regimen improves overall survival in acute myeloid leukemia patients

Combination regimen improves overall survival in acute myeloid leukemia patients

Study indicates a powerful treatment for pulmonary fibrosis

Study indicates a powerful treatment for pulmonary fibrosis

Epigenetics key to daily production of 10 billion blood cells without mistakes

Epigenetics key to daily production of 10 billion blood cells without mistakes

Clinical trial shows CAR-T cell therapy can be used for treating Hodgkin lymphoma

Clinical trial shows CAR-T cell therapy can be used for treating Hodgkin lymphoma

New approach is more effective in treating certain blood cancers

New approach is more effective in treating certain blood cancers

Reactivating divergent signaling pathways to enhance cancer treatment

Reactivating divergent signaling pathways to enhance cancer treatment

Josep Carreras Institute creates spin-off to develop CAR-T based therapies for leukemia

Josep Carreras Institute creates spin-off to develop CAR-T based therapies for leukemia

Rare inherited mutation in TP53 gene predisposes to a wide range of cancers

Rare inherited mutation in TP53 gene predisposes to a wide range of cancers

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia

Dual inhibitor therapy may be safer for patients with chronic lymphocytic leukemia

Researchers explore the reproduction of adenoviruses in cells

Researchers explore the reproduction of adenoviruses in cells

Molecular landscape of myelodysplastic/myeloproliferative neoplasms revealed

Molecular landscape of myelodysplastic/myeloproliferative neoplasms revealed

Engineered T-cells attack solid-tumor cancer cells from humans and mice

Engineered T-cells attack solid-tumor cancer cells from humans and mice

A metabolic enzyme could be a potential drug target for B cell lymphomas

A metabolic enzyme could be a potential drug target for B cell lymphomas

CAR T Cell Therapy: Potential For Considerable Savings

CAR T Cell Therapy: Potential For Considerable Savings

Developments in Engineered T Cells for Type 1 Diabetes

Developments in Engineered T Cells for Type 1 Diabetes

Deleting a key gene to create an immune cell with stronger anti-tumor activity

Deleting a key gene to create an immune cell with stronger anti-tumor activity

Researchers identify key gene essential for leukemia stem cells' survival

Researchers identify key gene essential for leukemia stem cells' survival